General Information About the Test
Test Process and Preparation
Screening tests (Double Test, Quadruple Test, Ultrasound) do not definitively prove the presence of a disease; they only indicate whether you are at "high risk." Diagnostic tests (Amniocentesis, Chorionic Villus Sampling), on the other hand, look directly at the baby's DNA and provide a 100% definitive "present or not present" result.
During this period, the mother's routine blood tests (Blood type, Hepatitis, Rubella screening), hearing the baby's heartbeat, and the Double Marker Test along with Nuchal Translucency (NT) measurement between the 11th and 14th weeks are generally performed.
Between the 16th and 20th weeks, the Quadruple Screen Test and, most importantly, the Detailed (Anomaly) Ultrasound, which examines all of the baby's organs in millimetric detail, are performed. When necessary, an oral glucose tolerance test (OGTT) is scheduled.
The information on this page is for informational purposes only. The results of medical tests must be evaluated by specialist physicians.
